Koyfin Home > Directory > Health Care > Abeona Therapeutics > Capital Expenditures

Abeona Therapeutics Capital Expenditures Chart (ABEO)

Abeona Therapeutics annual/quarterly Capital Expenditures from 2010 to 2020.
  • Abeona Therapeutics Capital Expenditures for the quarter ending June 06, 2020 was $-1m a -69.44% increase of 0m year over year
  • Abeona Therapeutics Capital Expenditures for the last 12 months ending June 06, 2020 was $-2m a -227.59% increase of 5m year over year
  • Abeona Therapeutics Annual Capital Expenditures for 2019 was $-6m a -46.50% increase of 3m from 2018
  • Abeona Therapeutics Annual Capital Expenditures for 2018 was $-9m a 90.70% decrease of -8m from 2017
  • Abeona Therapeutics Annual Capital Expenditures for 2017 was $-1m a 39.65% decrease of 0m from 2016
Other Cash Flow Metrics:
  • Abeona Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $-9m a 41.08% decrease of -4m year over year
  • Abeona Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-5m a 46.02% decrease of -2m year over year
  • Abeona Therapeutics Total Revenue for the quarter ending September 09, 2018 was $2m a 87.42% increase of 1m year over year
View Chart On Koyfin

Quarterly ABEO Capital Expenditures Data

06/2020$-1m
03/2020$0m
12/2019$0m
09/2019$-1m
06/2019$-4m
03/2019$-1m
12/2018$-1m
09/2018$-2m
06/2018$-3m
03/2018$-4m

Annual ABEO Capital Expenditures Data

2019$-6m
2018$-9m
2017$-1m
2016$-1m
2015$0m
2013$0m
2012$0m
2011$0m
2010$0m